Header Logo

Nancy Reau

Concepts (147)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatitis C, Chronic
12
2021
18
4.420
Why?
Antiviral Agents
10
2021
27
2.310
Why?
Liver Diseases
6
2022
15
2.080
Why?
Liver Transplantation
4
2021
30
2.030
Why?
Hepatitis C
7
2021
15
1.950
Why?
Pregnancy Complications
4
2022
26
1.720
Why?
Pregnancy Complications, Infectious
2
2019
15
1.070
Why?
Coinfection
2
2023
6
0.920
Why?
Humans
27
2023
12240
0.880
Why?
Pregnancy
7
2022
193
0.870
Why?
Sulfonamides
3
2020
22
0.840
Why?
Hepatitis D
1
2023
1
0.790
Why?
Quinoxalines
3
2020
4
0.750
Why?
Infectious Disease Transmission, Vertical
2
2019
6
0.740
Why?
Liver Diseases, Alcoholic
1
2021
15
0.690
Why?
Prejudice
1
2021
21
0.690
Why?
Living Donors
1
2021
6
0.690
Why?
Hepacivirus
7
2021
12
0.690
Why?
HIV Infections
2
2021
256
0.670
Why?
Patient Selection
1
2021
111
0.660
Why?
Practice Patterns, Physicians'
1
2021
68
0.650
Why?
Female
15
2022
6974
0.640
Why?
Obesity
1
2021
156
0.620
Why?
Hypertension, Pregnancy-Induced
1
2019
1
0.580
Why?
Liver Cirrhosis
6
2022
18
0.580
Why?
Benzimidazoles
1
2018
4
0.560
Why?
Kidney Transplantation
1
2018
51
0.530
Why?
Pregnancy Complications, Neoplastic
1
2016
2
0.470
Why?
Gastroenterology
1
2016
4
0.470
Why?
Advisory Committees
1
2013
8
0.390
Why?
Preventive Health Services
1
2013
7
0.390
Why?
Health Policy
1
2013
20
0.390
Why?
United States
6
2021
989
0.380
Why?
Liver Function Tests
2
2022
12
0.330
Why?
Ribavirin
2
2016
3
0.330
Why?
Cyclopropanes
3
2020
6
0.330
Why?
Treatment Outcome
7
2021
1478
0.320
Why?
Middle Aged
8
2021
4043
0.320
Why?
Liver Neoplasms
2
2022
47
0.290
Why?
Drug Therapy, Combination
4
2021
76
0.280
Why?
Carbamates
2
2020
2
0.280
Why?
Cholestasis, Intrahepatic
2
2019
3
0.260
Why?
Hepatitis B
2
2019
6
0.260
Why?
Fatty Liver
2
2019
13
0.260
Why?
Sustained Virologic Response
3
2021
3
0.260
Why?
Adult
6
2021
3557
0.260
Why?
Male
8
2021
6815
0.230
Why?
Young Adult
4
2021
863
0.220
Why?
Aged
7
2020
4000
0.220
Why?
Risk Factors
3
2023
1049
0.210
Why?
Mass Screening
2
2015
86
0.200
Why?
Hepatitis Delta Virus
1
2023
1
0.200
Why?
Hepatitis B virus
1
2023
1
0.200
Why?
Hepatitis B Surface Antigens
1
2023
4
0.200
Why?
Cost of Illness
1
2023
24
0.200
Why?
Prevalence
1
2023
175
0.190
Why?
Mastocytosis, Systemic
1
2022
6
0.190
Why?
Chemoembolization, Therapeutic
1
2022
4
0.190
Why?
Carcinoma, Hepatocellular
1
2022
9
0.190
Why?
Liver
1
2022
57
0.180
Why?
Selection Bias
1
2021
4
0.180
Why?
Fertility
1
2021
12
0.170
Why?
Pregnancy Outcome
1
2021
10
0.170
Why?
Aminoisobutyric Acids
2
2018
2
0.170
Why?
Proline
2
2018
5
0.170
Why?
Leucine
2
2018
7
0.170
Why?
Lactams, Macrocyclic
2
2018
3
0.170
Why?
Cost-Benefit Analysis
3
2019
46
0.170
Why?
Drug Administration Schedule
2
2018
84
0.170
Why?
Tissue Donors
1
2021
42
0.170
Why?
Attitude of Health Personnel
1
2021
66
0.170
Why?
Prognosis
2
2021
363
0.170
Why?
Benzofurans
1
2020
1
0.160
Why?
Amides
1
2020
9
0.160
Why?
Patient Reported Outcome Measures
2
2021
165
0.160
Why?
Imidazoles
1
2020
34
0.160
Why?
Forecasting
1
2019
36
0.150
Why?
Biomedical Research
1
2019
27
0.150
Why?
Hyperemesis Gravidarum
1
2019
1
0.150
Why?
Hepatitis, Autoimmune
1
2019
1
0.150
Why?
Surveys and Questionnaires
1
2021
546
0.140
Why?
Cohort Studies
3
2021
827
0.140
Why?
Pyrrolidines
1
2018
1
0.140
Why?
Transplant Recipients
1
2018
8
0.140
Why?
Internationality
1
2018
7
0.140
Why?
Infant, Newborn
1
2019
312
0.140
Why?
Graft Survival
1
2018
44
0.140
Why?
Graft Rejection
1
2018
30
0.140
Why?
Dose-Response Relationship, Drug
1
2018
179
0.140
Why?
Psychometrics
1
2018
95
0.130
Why?
Hospitalization
2
2016
158
0.130
Why?
Drug Resistance, Viral
1
2017
7
0.130
Why?
Drug Substitution
1
2017
3
0.130
Why?
Risk Assessment
1
2018
295
0.130
Why?
Sofosbuvir
1
2016
1
0.120
Why?
Heterocyclic Compounds, 4 or More Rings
1
2016
1
0.120
Why?
Macrocyclic Compounds
1
2016
1
0.120
Why?
Kidney Failure, Chronic
1
2017
61
0.120
Why?
Paracentesis
1
2016
1
0.120
Why?
Ascites
1
2016
2
0.120
Why?
Retrospective Studies
3
2020
1467
0.120
Why?
Eclampsia
1
2016
1
0.120
Why?
HELLP Syndrome
1
2016
1
0.120
Why?
Pre-Eclampsia
1
2016
4
0.120
Why?
Practice Guidelines as Topic
2
2014
116
0.120
Why?
Societies, Medical
1
2016
48
0.120
Why?
Directive Counseling
1
2015
4
0.110
Why?
Drug Interactions
1
2015
16
0.110
Why?
Disease Management
1
2016
59
0.110
Why?
Medication Adherence
1
2015
29
0.110
Why?
Hospitalists
1
2014
1
0.100
Why?
Cooperative Behavior
1
2014
25
0.100
Why?
Health Care Costs
1
2014
32
0.100
Why?
Quality of Health Care
1
2014
40
0.100
Why?
Interferon-alpha
1
2009
15
0.070
Why?
Polyethylene Glycols
1
2009
10
0.070
Why?
Recombinant Proteins
1
2009
90
0.070
Why?
Clinical Trials as Topic
1
2009
100
0.070
Why?
Aged, 80 and over
3
2020
2152
0.070
Why?
Cross-Sectional Studies
2
2021
400
0.070
Why?
Adolescent
2
2020
989
0.060
Why?
Hospital Costs
2
2016
29
0.050
Why?
Pyrroles
1
2022
15
0.050
Why?
Carbonic Anhydrase IX
1
2022
1
0.050
Why?
Epithelial Cell Adhesion Molecule
1
2022
1
0.050
Why?
Neoplasm, Residual
1
2022
5
0.050
Why?
Hypoxia
1
2022
14
0.050
Why?
Pyrazoles
1
2022
35
0.050
Why?
Infection Control
1
2021
76
0.040
Why?
Quality of Life
1
2022
261
0.040
Why?
Quality-Adjusted Life Years
1
2019
6
0.040
Why?
Comorbidity
1
2018
209
0.030
Why?
Pain Management
1
2018
74
0.030
Why?
Reproducibility of Results
1
2018
324
0.030
Why?
Viral Nonstructural Proteins
1
2016
1
0.030
Why?
Drug Combinations
1
2016
17
0.030
Why?
Serine Proteases
1
2016
4
0.030
Why?
Cost Savings
1
2016
15
0.030
Why?
Quality Indicators, Health Care
1
2016
13
0.030
Why?
Genotype
1
2016
169
0.030
Why?
Hospital Mortality
1
2016
72
0.030
Why?
Databases, Factual
1
2016
156
0.030
Why?
Length of Stay
1
2016
126
0.030
Why?
Time Factors
1
2016
695
0.030
Why?
Guideline Adherence
1
2014
30
0.030
Why?
Inpatients
1
2014
56
0.020
Why?
Chronic Disease
1
2014
186
0.020
Why?
Reau's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (147)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_